• Reference Citation Analysis
  • v
  • v
  • Find an Article
  • Find an Author
Download
Number Citation Analysis
1
Dallolio L, Gallè F, Masini A, Valeriani F, Ceciliani A, di Cagno A, Galeone D, Pecoraro P, Valerio G, Liguori G, Romano Spica V, Brandi G, Baldelli G, Capelli G, Coco D, Corradi M, Cortis E, Deiana P, Di Rosa E, Marini S, Mulato R, Parisi A, Pesce C, Riegger S, Staiano A, Siniscalco A, Trombetta M, Ubaldi F. Active breaks: a strategy to counteract sedentary behaviors for Health Promoting Schools. A discussion on their implementation in Italy. Ann Ig 2023;35:202-212. [PMID: 35788249 DOI: 10.7416/ai.2022.2532] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
2
Amagliani G, Baldelli G, Italiano P, Frisina P, Schiavano GF, Brandi G, De Santi M. Effect of COVID-19 isolation measures on physical activity of children and their parents, and role of the family environment: a cross-sectional study. Ann Ig 2023;35:159-177. [PMID: 35762445 DOI: 10.7416/ai.2022.2535] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
3
Amatori S, Sisti D, Perroni F, Brandi G, Rocchi MBL, Gobbi E. Physical activity, sedentary behaviour and screen time among youths with Down syndrome during the COVID-19 pandemic. J Intellect Disabil Res 2022;66:903-912. [PMID: 35445779 PMCID: PMC9115083 DOI: 10.1111/jir.12933] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 10/21/2021] [Revised: 03/17/2022] [Accepted: 04/06/2022] [Indexed: 06/14/2023]
4
Bocconcelli M, Natalucci V, Ferri Marini C, Annibalini G, Sisti D, Lucertini F, Vallorani L, De Santi M, Rocchi M, Barocci S, Flori M, Brandi G, Catalano V, Villarini A, Barbieri E, Emili R. 181P A randomized controlled trial on the efficacy of supervised exercise training in reducing IGF-1 levels in breast cancer survivors of the Movis’ cohort. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.216] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]  Open
5
Borad M, Javle M, Shaib W, Mody K, Bergamo F, Harris W, Damjanov N, Macarulla T, Brandi G, Masi G, Droz Dit Busset M, Boncompagni A, Dimova-Dobreva M, Engelhardt M, Saulay M, Halfdanarson T, Knox J, Abou-Alfa G, Personeni N, Mazzaferro V. 59P Efficacy of derazantinib in intrahepatic cholangiocarcinoma (iCCA) patients with FGFR2 fusions, mutations or amplifications. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.087] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]  Open
6
Tober N, Filippini D, Pagani R, Forti L, Burrafato G, Brandi G, Gennari A. P-144 Quality of life assessment in biliary tract cancer: A systematic review of phase 2 and 3 clinical trials published between 2010 and 2021. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.04.234] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]  Open
7
Rizzo A, Ricci AD, Brandi G. Bile cell‑free DNA: a game changer for management of biliary tract cancer? ESMO Open 2022;7:100389. [PMID: 35121524 PMCID: PMC8818922 DOI: 10.1016/j.esmoop.2022.100389] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2021] [Revised: 12/07/2021] [Accepted: 12/12/2021] [Indexed: 11/18/2022]  Open
8
Bögli SY, Utebay D, Smits N, Westphal LP, Hirsbrunner L, Unseld S, Keller E, Brandi G. Sex-related differences of invasive therapy in patients with aneurysmal subarachnoid hemorrhage. Acta Neurochir (Wien) 2022;164:2899-2908. [PMID: 35986220 PMCID: PMC9613555 DOI: 10.1007/s00701-022-05345-0] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2022] [Accepted: 08/11/2022] [Indexed: 02/01/2023]
9
Frega G, Kepp O, Turchetti D, Rizzo A, Pantaleo MA, Brandi G. Hypothesis on the possible relevance of the immunogenic cell death in the treatment of gestational trophoblastic neoplasms. Transl Oncol 2021;14:101224. [PMID: 34592590 PMCID: PMC8482038 DOI: 10.1016/j.tranon.2021.101224] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2021] [Revised: 08/31/2021] [Accepted: 09/10/2021] [Indexed: 11/30/2022]  Open
10
Bisello S, Bertini F, Tolento G, Renzulli M, Medici F, Benini A, Vallerossa D, Macchia G, Deodato F, Cilla S, Cellini F, Strigari L, Angelini A, Brandi G, Cammelli S, Morganti A, Buwenge M. PO-1236 Stereotactic body radiotherapy in unresectable intrahepatic cholangio-carcinoma: a systematic review. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)07687-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
11
Rizzo A, Frega G, Palloni A, Piemontese A, Di Federico A, Ricci A, Carloni R, Fabbri F, Novelli M, Tavolari S, Di Marco M, Ravaioli M, Brandi G. P-69 Intensive follow-up program and oncological outcomes of 278 biliary tract cancer patients after curative intent surgery: A single-center retrospective experience. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.05.124] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]  Open
12
Tovoli F, Dadduzio V, De Lorenzo S, Garajovà I, Marra F, Trevisani F, Pini S, Granito A, Zagonel V, Brandi G, Piscaglia F. 999P Real-life clinical data of cabozantinib for unresectable hepatocellular carcinoma. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.1115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]  Open
13
Emili R, Natalucci V, Marini C, Lucertini F, Vallorani L, Annibalini G, De Santi M, Donati Zeppa S, Agostini D, Gervasi M, Panico A, Sisti D, Rocchi M, Barocci S, Flori M, Brandi G, Stocchi V, Catalano V, Villarini A, Barbieri E. 238P Beneficial effects of exercise in oncology - MoviS: ‘Movement and Health Beyond Care’. Ann Oncol 2020. [PMCID: PMC7506414 DOI: 10.1016/j.annonc.2020.08.359] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]  Open
14
Baldelli G, De Santi M, Gervasi M, Annibalini G, Sisti D, Højman P, Sestili P, Stocchi V, Barbieri E, Brandi G. Correction to: The effects of human sera conditioned by high-intensity exercise sessions and training on the tumorigenic potential of cancer cells. Clin Transl Oncol 2020;23:195. [PMID: 32772345 DOI: 10.1007/s12094-020-02469-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
15
De Santi M, Zangara G, Baldelli G, Brandi G. Influence of parental habits and drug use in adolescents' physical activity: a case study of an Italian high school. Ann Ig 2020;32:541-548. [PMID: 32744585 DOI: 10.7416/ai.2020.2374] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
16
Massacesi M, Oliva N, Pucci L, Brandi G, De Santi M. Listeriolysin O antibodies detection in pregnant women: results from an Italian pilot study. Ann Ig 2020;31:326-332. [PMID: 31268117 DOI: 10.7416/ai.2019.2294] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
17
Romano Spica V, Gallè F, Baldelli G, Valeriani F, Di Rosa E, Liguori G, Brandi G. Swimming Pool safety and prevention at the time of Covid-19: a consensus document from GSMS-SItI. Ann Ig 2020;32:439-448. [PMID: 32578839 DOI: 10.7416/ai.2020.2368] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
18
Rizzo A, Ricci A, Frega G, Palloni A, Dall'Olio F, Lorenzo SD, Tavolari S, Abbati F, Vasuri F, Di Marco M, Tober N, Nigro M, Mosca M, Mollica V, Maggio I, Tovoli F, Cescon M, Serra C, Ambrosini V, Nanni C, Fanti S, Brandi G. PD-2 Role of pretreatment SUVmax on 18F-FDG PET and clinicopathological features in the prognostic stratification of newly diagnosed intrahepatic cholangiocarcinoma. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.04.458] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]  Open
19
Filippini DM, Grassi E, Palloni A, Carloni R, Casadei R, Ricci C, Serra C, Ercolani G, Brandi G, Di Marco M. Searching for novel multimodal treatments in oligometastatic pancreatic cancer. BMC Cancer 2020;20:271. [PMID: 32228504 PMCID: PMC7106565 DOI: 10.1186/s12885-020-06718-3] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2019] [Accepted: 03/05/2020] [Indexed: 01/05/2023]  Open
20
Viza D, Pizza G, De Vinci C, Brandi G, Ablashi D. Transfer Factor as an Option for Managing the COVID-19 Pandemic. Folia Biol (Praha) 2020;66:86-90. [PMID: 33069187] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
21
Frega G, Tavolari S, Indio V, Deserti M, Tarantino G, Palloni A, De Lorenzo S, Rizzo A, Astolfi A, Brandi G. Potentially actionable mutations in intrahepatic cholangiocarcinoma. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz413.069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
22
De Santi M, Baldelli G, Brandi G. Use of hormones in doping and cancer risk. Ann Ig 2019;31:590-594. [PMID: 31616903 DOI: 10.7416/ai.2019.2319] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
23
Zhu A, Galle P, Llovet J, Finn R, Kang YK, Yen C, Assenat E, Brandi G, Motomura K, Ohno I, Daniele B, Vogel A, Yamashita T, Hsu CH, Meyer T, Widau R, Schelman W, Wang C, Hsu Y, Kudo M. Prognostic and predictive value of baseline alpha-fetoprotein (AFP) in patients with advanced hepatocellular carcinoma (HCC) treated with ramucirumab from two phase III studies (REACH, REACH-2). Ann Oncol 2019. [DOI: 10.1093/annonc/mdz247.079] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
24
Kudo M, Galle P, Motomura K, Assenat E, Merle P, Brandi G, Daniele B, Okusaka T, Tomasek J, Borg C, Zagonel V, Morimoto M, Pracht M, Finn R, Llovet J, Homma G, Jen MH, Shinozaki K, Yoshikawa R, Zhu A. Efficacy and safety of ramucirumab (RAM) for advanced hepatocellular carcinoma (HCC) with elevated alpha-fetoprotein (AFP) following first-line sorafenib across age subgroups in two global phase III trials (REACH and REACH-2). Ann Oncol 2019. [DOI: 10.1093/annonc/mdz247.083] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
25
Meyer T, Finn R, Kudo M, Kang Y, Yen C, Galle P, Llovet J, Assenat E, Brandi G, Motomura K, Okusaka T, Hubner R, Karwal M, Baron A, Ikeda M, Liang K, Wang C, Widau R, Schelman W, Zhu A. Ramucirumab in advanced hepatocellular carcinoma and elevated alpha-fetoprotein following sorafenib: outcomes by prior transarterial chemoembolisation from two randomised, double-blind, placebo-controlled phase 3 studies (REACH-2 and REACH). Ann Oncol 2019. [DOI: 10.1093/annonc/mdz154.020] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
26
Bisello S, Palloni A, Buwenge M, Autorino R, Cellini F, Tagliaferri L, Gabriella M, Deodato F, Picardi V, Mignona S, Cilla S, Perri V, Tringali A, Galuppi A, Brandi G, Morganti A, Cammelli S, Valentini V, Mattiucci G. EP-1422 Unresectable biliary cancer: results of a pooled analysis of combined CHEMORADIOTHERAPY. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)31842-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
27
Tavolari S, Deserti M, Vasuri F, Curti S, Palloni A, Pinna AD, Cescon M, Frega G, De Lorenzo S, Barbera MA, Garajova I, Ricciardiello L, Malvi D, D'Errico-Grigioni A, Pantaleo MA, Brandi G. Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments. Eur J Cancer 2018;106:160-170. [PMID: 30528800 DOI: 10.1016/j.ejca.2018.11.005] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2018] [Revised: 10/26/2018] [Accepted: 11/01/2018] [Indexed: 12/27/2022]
28
Kang YK, Kudo M, Lim HY, Hsu CH, Vogel A, Brandi G, Cheng R, Carton I, Abada P, Hsu Y, Zhu A, Yen CJ. Efficacy and safety of ramucirumab (RAM) in Asian and non-Asian patients with advanced hepatocellular carcinoma (HCC) and elevated alpha-fetoprotein (AFP): Subgroup analysis from two randomized studies. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy432.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
29
Neuzillet C, Casadei Gardini A, Brieau B, Vivaldi C, Smolenschi C, Brandi G, Tougeron D, Filippi R, Vienot A, Silvestris N, Pointet AL, Murgioni S, Rousseau BC, Scartozzi M, Dahan L, Boussaha T, Crusz S, Meurisse A, Lievre A, Vernerey D. Prediction of overall survival with 2nd-line (L2OS) chemotherapy (CT) in patients with advanced biliary tract cancer (aBTC): AGEO CT2BIL cohort update and international multicenter external validations. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy282.148] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
30
Dadduzio V, Rizzato M, Ramondo G, Vivaldi C, Milella M, Brandi G, Cereda S, Murgioni S, Cardellino G, Filippi R, Santini D, Pasquini G, Intini R, Vaccaro V, Palloni A, Reni M, Musettini G, Gringeri E, Aliberti C, Zagonel V. Advanced intrahepatic cholangiocarcinoma (iCCA) treated with arterial-directed therapies (ADT): Outcomes and safety from a multicenter Italian experience. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy282.147] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
31
Santini D, Brandi G, Aprile G, Russano M, Cereda S, Leone F, Lonardi S, Fornaro L, Scartozzi M, Silvestris N, Barni S, Pantano F, Vincenzi B, Palloni A, Frega G, Casagrande M, Ferrari L, Dadduzio V, Intini R, Filippi R, Vasile E, Vivaldi C, Faloppi L, Brunetti O, Reni M, Aglietta M, Tonini G. Bone metastases in biliary cancers: A multicenter retrospective survey. J Bone Oncol 2018;12:33-37. [PMID: 30042924 PMCID: PMC6054714 DOI: 10.1016/j.jbo.2017.11.006] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2017] [Revised: 11/18/2017] [Accepted: 11/24/2017] [Indexed: 10/24/2022]  Open
32
Pileri S, Brandi G, Rivano MT, Govoni E, Martinelli G. Report of a Case of Non-Hodgkin's Lymphoma of Large Multilobated Cell Type with B-Cell Origin. Tumori 2018;68:543-8. [PMID: 6984803 DOI: 10.1177/030089168206800616] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
33
Bazzocchi F, Brandi G, Pileri S, Mancuso A, Massaro A, Martinelli G. Clinical and Pathologic Prognostic Features of Leiomyosarcoma of the Uterus. Tumori 2018;69:75-7. [PMID: 6836752 DOI: 10.1177/030089168306900113] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
34
Filippi R, Frega G, Vivaldi C, Casadei Gardini A, Aprile G, Silvestris N, Satolli M, Faloppi L, Santini D, Lutrino E, Vasile E, Valgiusti M, Basile D, Brunetti O, Spadi R, Russano M, Scartozzi M, Cagnazzo C, Brandi G, Leone F. Biliary tract carcinoma and chronic viral hepatitis in Italy: the GICO (Gruppo Italiano COlangiocarcinoma) experience. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx425.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]  Open
35
Abbati F, Massucci M, Mollica V, Palloni A, Barbera M, Frega G, Ferracin M, Porcellini E, Brandi G, Biasco G, Garajová I. Focus on metastatic right-sided colon cancer: the best overall response to the first-line non-EGFR treatment correlates with better overall survival. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx422.037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
36
Brandi G, Deserti M, Astolfi A, Indio V, Farioli A, Mattioli S, Palloni A, De Lorenzo S, Garajova I, Vasuri F, Pinna A, Cescon M, Tavolari S. Whole-exome sequencing analysis identifies recurrent mutation rate in BAP1 gene in intrahepatic cholangiocarcinoma patients exposed to asbestos. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx425.011] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
37
Massucci M, Francesca A, Veronica M, Palloni A, Frega G, Ferracin M, Porcellini E, Brandi G, Biasco G, Garajová I. Radically resected stage III colorectal cancer: sidedness and prognosis. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx422.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
38
Marinelli I, Fuccio L, Guido A, Farioli A, Panni V, Ercolani G, Brandi G, Cammelli S, Galuppi A, Macchia G, Frakulli R, MAttiucci G, Cellini F, Buwenge M, Renzulli M, Deodato F, Cilla S, Valentini V, Tombolini V, Golfieri R, Morganti A. PO-0689: clinical target volume in biliary carcinoma: a systematic review of pathological studies. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)31126-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
39
Ruggiero C, Bonamassa L, Pelini L, Prioletta I, Cianferotti L, Metozzi A, Benvenuti E, Brandi G, Guazzini A, Santoro GC, Mecocci P, Black D, Brandi ML. Early post-surgical cognitive dysfunction is a risk factor for mortality among hip fracture hospitalized older persons. Osteoporos Int 2017;28:667-675. [PMID: 27717957 DOI: 10.1007/s00198-016-3784-3] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/13/2016] [Accepted: 09/22/2016] [Indexed: 01/29/2023]
40
Gatto L, Nannini M, Saponara M, Di Scioscio V, Beltramo G, Frezza GP, Ercolani G, Pinna AD, Astolfi A, Urbini M, Brandi G, Biasco G, Pantaleo MA. Radiotherapy in the management of gist: state of the art and new potential scenarios. Clin Sarcoma Res 2017;7:1. [PMID: 28078078 PMCID: PMC5223331 DOI: 10.1186/s13569-016-0065-z] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2016] [Accepted: 12/16/2016] [Indexed: 12/14/2022]  Open
41
Brandi G, Casabianca A, Schiavano G, Rossi L, Fraternale A, Albano A, Magnani M. Efficacy and Toxicity of Long-Term Administration of 2′,3′-dideoxycytidine in the LP-BM5 Murine-Induced Immunodeficiency Model. ACTA ACUST UNITED AC 2016. [DOI: 10.1177/095632029500600304] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
42
Brandi G, Puddu P, Casabianca A, Cianfriglia M, Magnani M. The Inhibitory Effect of ddC on Human Immunodeficiency Virus Replication Diminishes in Cells that are Chronically Exposed to the Drug. ACTA ACUST UNITED AC 2016. [DOI: 10.1177/095632029700800205] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
43
Magnani M, Casabianca A, Rossi L, Fraternale A, Brandi G, Silvotti L, Piedimonte G. Inhibition of HIV-1 and LP-BM5 Replication in Macrophages by Dideoxycytidine and Dideoxycytidine 5′-Triphosphate. ACTA ACUST UNITED AC 2016. [DOI: 10.1177/095632029500600505] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
44
Brandi G, Cereda S, Pantano F, Russano M, Lonardi S, Leone F, Reni M, Marsico V, Filippi R, Delcuratolo S, Fornaro L, Vasile E, Vivaldi C, Aprile G, Pisconti S, Luca F, Aieta M, Tonini G, Santini D. Natural history of skeletal disease in primary biliary cancers. National survey on behalf of GICO group (Gruppo Italiano Colangiocarcinoma – Onlus). Ann Oncol 2015. [DOI: 10.1093/annonc/mdv344.19] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
45
Garajová I, Brandi G, Biasco G, Deserti M, Tavolari S, Palloni A, Verlicchi L, Le Large T, Di Piazza D, Giovannetti E. MiR-21 expression as prognostic biomarker in extrahepatic but not intrahepatic radically resected cholangiocarcinomas. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv344.27] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
46
Fornaro L, Cereda S, Leone F, Aprile G, Lonardi S, Silvestris N, Santini D, Milella M, Palloni A, Barbera A, Ferrari L, Filippi R, Bergamo F, Vivaldi C, Caparello C, Musettini G, Pasquini G, Falcone A, Reni M, Brandi G, Vasile E. Second-line chemotherapy (CT2) in advanced biliary tract cancer (aBTC) patients (pts) progressed to first-line chemotherapy (CT1) with gemcitabine plus platinum: where are we now? Ann Oncol 2015. [DOI: 10.1093/annonc/mdv344.14] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]  Open
47
Garajová I, Brandi G, Biasco G, Deserti M, Tavolari S, Palloni A, Verlicchi L, Le Large T, Giovannetti E. 219 MiR-21 expression correlates with prognosis in extrahepatic radically resected cholangiocarcinomas treated with gemcitabine-based adjuvant chemotherapy. Eur J Cancer 2015. [DOI: 10.1016/s0959-8049(16)30106-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
48
Chau I, Park J, Ryoo B, Yen C, Poon R, Pastorelli D, Blanc J, Kudo M, Pfiffer T, Hatano E, Chung H, Kubackova K, Phelip J, Brandi G, Ohkawa S, Li C, Okusaka T, Yang L, Abada P, Zhu A. 2337 Ramucirumab (RAM) as a second-line treatment in patients with advanced hepatocellular carcinoma (HCC) following first-line therapy with sorafenib in the randomized phase III REACH study: Analysis of alpha-fetoprotein (AFP) kinetics during treatment. Eur J Cancer 2015. [DOI: 10.1016/s0959-8049(16)31253-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
49
Fornaro L, Vivaldi C, Brandi G, Cereda S, Aprile G, Santini D, Silvestris N, Lonardi S, Leone F, Milella M, Caparello C, Musettini G, Pasquini G, Vasile E. P-147 Outcome of second-line chemotherapy (CT2) after first-line CT (CT1) with platinum plus gemcitabine in advanced biliary tract cancer (aBTC): is it worthwhile? Ann Oncol 2015. [DOI: 10.1093/annonc/mdv233.147] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
50
Marsico V, Vasile E, Brandi G, Leone F, Santini D, Aprile G, Cereda S, Silvestris N, Milella M, Bergamo F, Fornaro L, Bolshinsky M, Paladina I, Lonardi S, Aliberti C. P-115 Transarterial Chemo-Embolization (TACE) and Radio-Embolization (TARE) in the combined modality treatment of advanced biliary tract cancer (aBTC): evaluation of feasibility and activity. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv233.115] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
PrevPage 1 of 5 12345Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA